Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
1.990
-0.020 (-1.00%)
At close: Aug 11, 2026, 4:00 PM EDT
2.010
+0.020 (1.01%)
After-hours: Aug 11, 2026, 6:23 PM EDT
Sera Prognostics Revenue
Sera Prognostics had revenue of $14.00K in the quarter ending March 31, 2026, a decrease of -63.16%. This brings the company's revenue in the last twelve months to $57.00K, down -50.43% year-over-year. In the year 2025, Sera Prognostics had annual revenue of $81.00K with 5.19% growth.
Revenue (ttm)
$57.00K
Revenue Growth
-50.43%
P/S Ratio
1,367.12
Revenue / Employee
$792
Employees
72
Market Cap
77.93M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 81.00K | 4.00K | 5.19% |
| Dec 31, 2024 | 77.00K | -229.00K | -74.84% |
| Dec 31, 2023 | 306.00K | 38.00K | 14.18% |
| Dec 31, 2022 | 268.00K | 186.00K | 226.83% |
| Dec 31, 2021 | 82.00K | 57.00K | 228.00% |
| Dec 31, 2020 | 25.00K | -11.00K | -30.56% |
| Dec 31, 2019 | 36.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xtant Medical Holdings | 121.91M |
| Outset Medical | 117.80M |
| Pulmonx | 87.44M |
| CVRx, Inc. | 61.19M |
| LENSAR | 57.70M |
| Myomo | 43.26M |
| electroCore | 36.97M |
| Rapid Micro Biosystems | 35.18M |
SERA News
- 13 days ago - SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026 - PRNewsWire
- 27 days ago - Sera Prognostics management to meet virtually with Craig-Hallum - TheFly
- 4 weeks ago - Sera Prognostics’ PreTRM Test shows efficacy guiding first-time pregnancy care - TheFly
- 4 weeks ago - PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE - PRNewsWire
- 6 weeks ago - SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS - PRNewsWire
- 6 weeks ago - Sera Prognostics part of ARPA-H award for birth safety test development - TheFly
- 6 weeks ago - SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH - PRNewsWire
- 7 weeks ago - SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY - PRNewsWire